Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by PerkinElmer, Inc.
< Previous
1
2
Next >
PerkinElmer Board Declares Quarterly Dividend
April 25, 2023
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
March 13, 2023
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
February 24, 2023
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer to Present at Upcoming Investor Conferences
February 22, 2023
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022
February 14, 2023
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Board Declares Quarterly Dividend
January 26, 2023
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
November 21, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Announces Financial Results for the Third Quarter of 2022
November 08, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Board Declares Quarterly Dividend
October 26, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook
October 17, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
September 26, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Announces Finance Leadership Transition
August 17, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Announces Financial Results for the Second Quarter of 2022
August 01, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company
August 01, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Board Declares Quarterly Dividend
July 22, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors
July 22, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Schedules Earnings Call for Thursday, August 4, 2022
July 14, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Introduces Next Generation, Automated Gas Chromatography Platform
June 21, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Expands Food Safety Testing Portfolio with AOAC Certified Microbial Count Plates
June 07, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Launches BioQule NGS System to Automate Library Preparation
June 06, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing
May 16, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Announces Financial Results for the First Quarter of 2022
May 03, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Board Declares Quarterly Dividend
April 28, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Schedules Earnings Call for Tuesday, May 3, 2022
April 12, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System
April 07, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification
April 04, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer’s SIRION Biotech Teams with Centre for Genomic Regulation to Develop New Generation AAV Vectors for Type 1 and Type 2 Diabetes Gene Therapy
February 16, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
February 10, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus
February 03, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021
February 01, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Tickers
PKI
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.